SO-10 Phase 2 study of futibatinib in patients with specific FGFR aberrations: Activity in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplification

SO-10 Phase 2 study of futibatinib in patients with specific FGFR aberrations: Activity in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplification

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 34; pp. S165 - S166
Main Authors: Satoh, T., Barthélémy, P., Nogova, L., Honda, K., Iwasa, S., Lee, K., Rha, S., Ajani, J., Hangai, N., Liu, S., Kremer, J., Mina, M., Shitara, K.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-06-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2023.04.482